The prognostic value of beta-1 blockers in patients with non-small-cell lung carcinoma treated with pembrolizumab
Yasmin Leshem, Tal Etan, Yardenna Dolev, Alla Nikolaevski‐Berlin, Mor Miodovnik, Sivan Shamai, Ofer Merimsky, Ido Wolf, Ofer Havakuk, Maor Tzuberi, Yan Topilsky, Shmuel Banai, Zach Rozenbaum, Michal Laufer‐Perl
Topics & Concepts
MedicinePembrolizumabBETA (programming language)Internal medicineOncologyCarcinomaLungValue (mathematics)ImmunotherapyCancerComputer scienceMachine learningProgramming languageCancer, Stress, Anesthesia, and Immune ResponseCancer Immunotherapy and BiomarkersInflammatory mediators and NSAID effects